Epilepsy: evidence brief
Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/epilepsy.html
Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.
Medicines with registered trials
Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.
- Lacosamide 6 trials
- Brivaracetam 2.5 mg 2 trials
- Levetiracetam 2 trials
- Topiramate 2 trials
- Air polishing with erythritol powder 1 trial
- Almotriptan malate 1 trial
Non-drug approaches tested
Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.
- Transcranial brain stimulation (tDCS, TMS) 31 trials · 17 completed · 6 with results
- Vagus and cranial nerve stimulation 32 trials · 10 completed · 6 with results
- Care coordination, navigation and outreach 10 trials · 5 completed · 3 with results
- Melatonin 3 trials · 2 completed · 2 with results
- Education, coaching and self-management 26 trials · 14 completed · 1 with results
- Peripheral electrical and electromagnetic stimulation 9 trials · 4 completed · 1 with results
Natural products (RepurpOS Moderate tier)
Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.
- Omega-3 Fatty Acids
- Cannabidiol (CBD)
- Folic Acid (Vitamin B9)
- Melatonin
- Black Seed Oil
Biomarkers reported
Direction in patients compared with the stated comparison group, as reported in the cited study.
- Ammonia higher · Vakrinou et al. 2022
- Creatine Kinase higher · Paltrinieri et al. 2017
- GFAP higher · Runtz et al. 2018
- High-Mobility Group Box 1 (HMGB1) higher · Walker et al. 2022
- Interleukin-6 higher · Tsuji et al. 2011
- Lactate higher · Chatzikonstantinou et al. 2015
Trials recruiting
Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical… NCT07600736
- A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients… NCT07594158
- A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of… NCT07723963
- Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in… NCT06623994
- Spatial Scene Recognition Memory in Epilepsy Surgery NCT07580183
- An Examination of Cognitive and Sensorimotor Processes in Patients With Epilepsy NCT00859794
What we don't know yet
Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.
- Among 30 trials of cognitive training and education found, none measured inflammation and other biomarkers 54 trials of other approaches did
- Among 10 trials of care delivery and health services found, none measured inflammation and other biomarkers 54 trials of other approaches did
- Among 9 trials of other devices and digital tools found, none measured inflammation and other biomarkers 54 trials of other approaches did
- Diet, fasting and nutrition: symptom severity and disease activity 26 trials, no results posted yet
- Mind-body and psychological approaches: quality of life 14 trials, no results posted yet